Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

NCT05314738 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT05314738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05314738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Lead sponsor
Glaukos Corporation
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 8, 2022
Completion date
February 28, 2026
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

progressive keratoconus